中华神经科杂志
中華神經科雜誌
중화신경과잡지
Chinese Journal of Neurology
2009年
2期
75-78
,共4页
巫嘉陵%王纪佐%王世民%安中平
巫嘉陵%王紀佐%王世民%安中平
무가릉%왕기좌%왕세민%안중평
卒中%疾病严重程度指数%预后
卒中%疾病嚴重程度指數%預後
졸중%질병엄중정도지수%예후
Stroke%Severity of illness index%Prognosis
目的 评价脑卒中患者临床神经功能缺损程度评分的信度和效度.方法 222例急性脑卒中患者,分别由不同评定者于入院当天、入院第14天、发病后第90天对同一例脑卒中患者进行临床神经功能缺损程度评分.重测信度与评定者间信度用Kappa值表示,分半信度、内部一致性信度用Croubach α值表示.同时效度、预测效度采用Spearman相关分析.结构效度采用因子分析的方法,其中脑梗死患者根据英国牛津郡社区脑卒中项目(OCSP)分型评定3种不同梗死类型的临床神经功能缺损程度评分的结构效度.结果 所有条目重测信度均>0.6,评定者间信度中条目"步行能力"为0.542,分半信度0.911,Cronbach α值为0.886,不同评定方式间信度显示"上肢肌力"、"手肌力"的信度分别为0.393、0.386.其与NIHSS评定结果呈正相关(均P=0.000),不同OCSP分型患者神经功能缺损程度评分与NIHSS评分结果均相关,且与发病后90 d的Barthel指数和改良Rankin评分均相关.结论 临床神经功能缺损程度评分内部一致性信度较高,其与NIHSS有同时效度,对脑卒中预后有预测效度;对部分前循环梗死患者的结构效度最好,可以用来评定椎-基底动脉系统的脑卒中,但并不敏感.
目的 評價腦卒中患者臨床神經功能缺損程度評分的信度和效度.方法 222例急性腦卒中患者,分彆由不同評定者于入院噹天、入院第14天、髮病後第90天對同一例腦卒中患者進行臨床神經功能缺損程度評分.重測信度與評定者間信度用Kappa值錶示,分半信度、內部一緻性信度用Croubach α值錶示.同時效度、預測效度採用Spearman相關分析.結構效度採用因子分析的方法,其中腦梗死患者根據英國牛津郡社區腦卒中項目(OCSP)分型評定3種不同梗死類型的臨床神經功能缺損程度評分的結構效度.結果 所有條目重測信度均>0.6,評定者間信度中條目"步行能力"為0.542,分半信度0.911,Cronbach α值為0.886,不同評定方式間信度顯示"上肢肌力"、"手肌力"的信度分彆為0.393、0.386.其與NIHSS評定結果呈正相關(均P=0.000),不同OCSP分型患者神經功能缺損程度評分與NIHSS評分結果均相關,且與髮病後90 d的Barthel指數和改良Rankin評分均相關.結論 臨床神經功能缺損程度評分內部一緻性信度較高,其與NIHSS有同時效度,對腦卒中預後有預測效度;對部分前循環梗死患者的結構效度最好,可以用來評定椎-基底動脈繫統的腦卒中,但併不敏感.
목적 평개뇌졸중환자림상신경공능결손정도평분적신도화효도.방법 222례급성뇌졸중환자,분별유불동평정자우입원당천、입원제14천、발병후제90천대동일례뇌졸중환자진행림상신경공능결손정도평분.중측신도여평정자간신도용Kappa치표시,분반신도、내부일치성신도용Croubach α치표시.동시효도、예측효도채용Spearman상관분석.결구효도채용인자분석적방법,기중뇌경사환자근거영국우진군사구뇌졸중항목(OCSP)분형평정3충불동경사류형적림상신경공능결손정도평분적결구효도.결과 소유조목중측신도균>0.6,평정자간신도중조목"보행능력"위0.542,분반신도0.911,Cronbach α치위0.886,불동평정방식간신도현시"상지기력"、"수기력"적신도분별위0.393、0.386.기여NIHSS평정결과정정상관(균P=0.000),불동OCSP분형환자신경공능결손정도평분여NIHSS평분결과균상관,차여발병후90 d적Barthel지수화개량Rankin평분균상관.결론 림상신경공능결손정도평분내부일치성신도교고,기여NIHSS유동시효도,대뇌졸중예후유예측효도;대부분전순배경사환자적결구효도최호,가이용래평정추-기저동맥계통적뇌졸중,단병불민감.
Objective To study the reliability and validity of the clinical neurologic deficit scale in evaluating stroke patients. Methods A total of 222 inpatients with acute stroke onset were included in the study. They were assessed when admitted, at the 14th and 90th day of hospitalization by different physicians using the clinical neurologic deficit scale. Intrarater and interrater reliability were determined using Kappa correlation. The split-half rehability and internal consistency were evaluated using Cranbach's a coefficient. Concurrent validity and the predictive validity were determined by spearman rank correlation coefficients. Construct validity was assessed by the factor analysis and the construct validity of the scale was measured according to the classifications of the Oxfordshire Community Stroke Project ischemic stroke subtypes in the patients with cerebral infarction. Results The scores of intrarater reliability in all items were higher than 0.6, the score of interrater reliability in the item "walking" was 0.542, the split-half reliability and the internal consistency were good as demonstrated by the score of 0.911 and 0.886 respectively, and assessment of reliability of different methods showed that "strength in upper limb" and "strength in hand", were poor as shown by the score of 0.393 and 0.386 respectively. The scale is highly correlated with the NIHSS ( both P=0.000) in both total and subtypes of stroke patients according to the classifications of the Oxfordshire Community Stroke Project by concurrent validity analysis. There was a high correlation between the scores of the scale and Barthel Index and the modified Rankin scales at the 90th day of hospitalization (both P=0.000). Conclusions The clinical neurologic deficit scale has a good internal consistency. There is concurrent validity between the scale and the NIHSS and could predict stroke outcome. Factor analysis of the scale displays the best construct validity in the patients with partial anterior circulation infarction, and could be used to evaluate the focus of vertebrobasilar artery despite its insensitivity.